SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001013762-14-001287
Filing Date
2014-11-06
Accepted
2014-11-06 17:14:08
Documents
3
Period of Report
2014-10-31
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 DELMAR PHARMACEUTICALS, INC. FORM 8-K f8k110614_delmarpharma.htm 8-K 20838
2 EXHIBIT 10.1 f8k110614ex10i_delmarpharma.htm EX-10.1 59415
3 EXHIBIT 10.2 f8k110614ex10ii_delmarpharma.htm EX-10.2 6863
  Complete submission text file 0001013762-14-001287.txt   88382
Mailing Address SUITE 720-999 WEST BROADWAY VANCOUVER A1 V5Z 1K5
Business Address SUITE 720-999 WEST BROADWAY VANCOUVER A1 V5Z 1K5 (604) 629-5989
DelMar Pharmaceuticals, Inc. (Filer) CIK: 0001498382 (see all company filings)

IRS No.: 990360497 | State of Incorp.: NV | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 000-54801 | Film No.: 141201743
SIC: 2834 Pharmaceutical Preparations